Sunday, June 15, 2025

Latest

Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share

Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus Wellness (TSX: NUMI) will be acquiring Novamind Inc (CSE: NM) in an all-stock transaction. The proposed transaction is being pushed as a means of creating a “North American leader in psychedelic therapy and research.”

The proposed transaction is expected to result in Numinus having operations consisting of thirteen wellness clinics, four research facilities, and a bioanalytical lab, with the firm to have clinical trials underway for LSD, ketamine, MDMA, and psilocybin. The firm has referred to the pro-forma offerings as a “comprehensive clinical research offering,” based on Novamind’s DEA Schedule 1 licenses for research and Numinus’ own Health Canada licenses.

From a financial perspective, the combined entity is expected to have annual revenues of roughly $10.0 million on a pro-forma basis, while the combination is expected to result in synergies of roughly $3.0 million per year. Gross margins are estimated to be roughly 37.9% on a post-transaction basis. The path to profitability is also said to be shortened, although no specifics are provided.

Numinus’ current executive team is said to be relatively unchanged, with key personnel from Novamind entering employment agreements effective upon closing.

The transaction will see total consideration for Novamind to consist of $26.2 million on a fully diluted basis. Shareholders of Novamind are to receive 0.84 of a Numinus share for each share held, equivalent to a price per share of $0.44, which is a 51% premium to the 20-day volume weighted average price of the company.

While the premium is rather significant, it should be noted that the sales price represents a major loss to the majority of shareholders. Novamind debuted on the public markets last January, opening at a price of $1.50 per share. It didn’t sink below the $0.44 mark until well over a year later in January 22, after which it continued to fall as low as $0.18.

What’s more, as recently as January the company raised funds, at the time selling $5.0 million worth of stock at a price of $0.40 per unit to an institutional investor.

The transaction is expected to close in June 2022, following shareholder approvals of the transaction. Upon closing, Novamind shareholders will hold 18% of Numinus on a post-transaction basis.

Numinus Wellness last traded at $0.53 on the TSX.


Information for this briefing was found via Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Silver: The Santa Elena Mine

Equinox Gold: Guidance Cut After Issues At Greenstone

Simply Solventless Q4 Earnings: So Much For Guidance

Recommended

NexGen Energy Receives Approval For Site Expansion At Rook I Project

ESGold Sees Installation Of Humphrey Spirals Completed At Montauban

Related News

Numinus Completes First Legal Harvest of Psychedelic Mushrooms

Numinus Wellness (TSXV: NUMI) has become the first publicly issued firm to legally complete a...

Thursday, October 22, 2020, 09:15:00 AM

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after...

Monday, September 20, 2021, 02:41:00 PM

Numinus Wellness To Acquire MedBright AI In Bid To Add Artificial Intelligence To Portfolio

Numinus Wellness (TSX: NUMI) is set to get into the artificial intelligence business. The firm...

Thursday, June 20, 2024, 09:41:47 AM

Numinus Wellness Announces Expansion To Research Lab

Numinus Wellness (TSXV: NUMI) has expansion on its mind. The company this morning announced that...

Tuesday, March 9, 2021, 08:18:23 AM

Numinus Wellness’ Study On MDMA-Assisted Therapy For PTSD Gets Health Canada Nod

Numinus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada...

Monday, July 12, 2021, 09:49:00 AM